F Braido

Author PubWeight™ 21.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012 2.17
2 A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005 1.51
3 Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy 2010 1.45
4 Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003 1.35
5 Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003 1.13
6 ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 2008 1.05
7 Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2009 0.98
8 The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. Allergy 2008 0.95
9 Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011 0.88
10 A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy 2005 0.86
11 Adherence to treatment: assessment of an unmet need in asthma. J Investig Allergol Clin Immunol 2006 0.86
12 Sleep disturbances in allergic diseases. Allergy 2006 0.85
13 Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013 0.83
14 Asthma treatment: 'magic bullets which seek their own targets'. Allergy 2007 0.83
15 Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol 2011 0.82
16 FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies. Panminerva Med 2013 0.81
17 Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? Rhinology 2014 0.81
18 COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. Pulm Pharmacol Ther 2012 0.79
19 The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate. J Biol Regul Homeost Agents 2011 0.78
20 The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage. Eur Rev Med Pharmacol Sci 2014 0.78
21 New life for macrolides. Minerva Med 2013 0.77
22 Mixed infection by Staphylococcus and Candida, and Wegener's granulomatosis. Monaldi Arch Chest Dis 1996 0.77
23 Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy 2010 0.75
24 Do Asthmatic Patients and Their Physicians Agree on the Presence and Severity of Allergic Rhinitis? J Investig Allergol Clin Immunol 2015 0.75
25 Continuing Medical Education: an international reality. Allergy 2005 0.75
26 Oral and sublingual immunotherapy: general aspects and critical considerations. Wien Med Wochenschr 1999 0.75
27 Wellbeing, illness perception and coping strategies in Italian Celiac patients. Int J Immunopathol Pharmacol 2013 0.75
28 Cross-cultural adaptation and linguistic validation of the Spanish version of the drug hypersensitivity quality of life questionnaire. J Investig Allergol Clin Immunol 2013 0.75
29 Anxiety and depression in cystic fibrosis. Minerva Med 2015 0.75